O&D BioTech Group CO., Limited
1 clinical trials · Sponsor
◉ Watch O&D BioTech Group CO., Limited
| Record | Firm | Date |
|---|---|---|
| Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma (NCT07369895) | O&D BioTech Group CO., Limited | 2025-10-28 |
Track O&D BioTech Group CO., Limited automatically
Every clearance here is in the API, with alerts when new ones post.